Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell lines. Influence of IL-10, Follistatin, activin-A, and DHT

International Journal of Oncology

Volumn 14, Issue 6, 1999, Pages 1185-1195

  Wang, M ^a   Liu, A ^a   Garcia, F U ^a   Rhim, J S ^b   Stearns, M E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Activin A; Basal cell keratin; Dihydrotestosterone; Follistatin; IL 10; Prostate specific antigen; Prostatic intraepithelial neoplasia

Indexed keywords

ACTIVIN; ANDROGEN; ANDROSTANOLONE; FOLLISTATIN; GLYCOPROTEIN; GROWTH PROMOTOR; IMMUNOLOGICAL ADJUVANT; INHIBIN; INTERLEUKIN 10; PRASTERONE;

ANIMAL; ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIVISION; CELL LINE; CLONOGENIC ASSAY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIGHT; MALE; MICROSCOPY; MOUSE; MOUSE MUTANT; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; VIROLOGY; VIRUS CELL TRANSFORMATION; WESTERN BLOTTING;

ACTIVINS; ADJUVANTS, IMMUNOLOGIC; ANDROGENS; ANIMALS; BLOTTING, WESTERN; CELL ADHESION; CELL DIVISION; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, VIRAL; COLONY-FORMING UNITS ASSAY; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLISTATIN; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; INHIBINS; INTERLEUKIN-10; LIGHT; MALE; MICE; MICE, SCID; MICROSCOPY; PAPILLOMAVIRIDAE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0033141456     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.6.1185     Document Type: Article

References (46)

1. Bostwick DG, Pacelli A and Lopez-Beltran A: Molecular biology of prostatic intraepithelial neoplasia. Prostate 29: 117-134, 1996.
2. Grayhack JT, Lee C and Brand W: The effect of testicular irradiation on established BPH in the dog: evidence of a non-steroidal testicular factor for BPH maintenance. J Urol 134: 1276-1281, 1985.
3. Wrana JL, Attisano L, Carcamo J, Zentell A, Doody J, Laiho M, Wang X and Massague J: TGF-β signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014, 1992.
4. Myers RB, Kudlow JE and Grizzle WE: Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic in hyperplasia. Mod Pathol 6: 733-737, 1993.
5. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE and Macoska JA: Comparative analysis of epidermal growth factor receptor gene expression and protein product in benign, premalignant, and malignant prostate tissue. Prostate 25: 199-205, 1994.
6. Maddy SQ, Chisholm GD, Busuttil A and Habib FK: Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumor. Br J Cancer 60: 41-44, 1989.
7. Ibrahim GK, Kerns BM, MacDonald JA, Ibrahim SN, Kinney RB, Humphrey PA and Robertson CN: Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol 149: 170-173, 1993.
8. Montone KT and Tomaszewski JE: In situ hybridization for epidermal growth factor receptor (EGFR) external domain transcripts in prostatic adenocarcinoma. J Clin Lab Anal 7: 188-195, 1993.
9. Maygarden SJ, Strom S and Ware JL: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia. Arch Pathol Lab Med 116: 269-273, 1992.
10. Fudge K, Bostwick DG and Stearns ME: Platelet-derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasia. Prostate 29: 282-286, 1996.
11. Ferguson J, Zincke H, Ellison E, Bergstrahl E and Bostwick DG: Decrease of prostatic intraepithelial neoplasia (PIN) following androgen deprivation therapy in patients with stage T3 carcinoma treated by radical prostatectomy. Urology 44: 91-95, 1994.
12. Montironi R, Magi-Galluzzi C, Muzzonigro G, Prete E, Polito M and Fabris G: Effects of combination endocrine treatment on normal prostate, prostatic intraepithelial neoplasia, and prostatic adenocarcinoma. J Clin Pathol 47: 906-913, 1994.
13. Thompson DM and Gill GN: The EGF receptor, structure, regulation, and potential role in malignancy. Cancer Surv 4: 767-788, 1985.
14. Eklov S, Funa K, Nordgren H, Olofsson A, Kanzaki T, Miyazono K and Nilsson S: Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue. Cancer Res 53: 3193-3197, 1993.
15. Dalkin AC, Gilrain JT, Bradshaw D and Myers CE: Activin inhibition of prostate cancer cell growth: selective actions on androgen-responsive LNCaP cells. Endocrinology 137: 5230-5235, 1996.
16. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF Jr and Sluss PM: Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology 137: 5476-5483, 1996.
17. De Paolo LV, Bicsak TA, Erickson GF, Shimasaki S and Ling N: Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proc Soc Exp Biol Med 198: 500-512, 1991.
18. Rhim JS, Webber MM, Bello D, Lee MS, Arnstein P, Cheng L-S and Jay G: Stepwise immortalization and transformation of adult human prostate epithelial cells by a combination of HPV-18 and v-Ki-ras. Proc Natl Acad Sci USA 91: 11874-11878, 1994.
19. Stearns M, Wang M and Stearns ME: Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol Res 7: 173-181, 1995.
20. Liang P and Pardee AB: Differential display of eucaryotic messenger RNA by means of the polymerase chain reaction. Science 257: 967, 1992.
21. Peehl DM, Leung GK and Wong ST: Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 277: 967-969, 1993.
22. Brawer MK, Bostwick DG, Peehl DM and Stamey TA: Keratin protein in human prostatic tissue and cell culture. Ann NY Acad Sci 455: 729-731, 1986.
23. Towbin H, Staehelin T and Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350-4354, 1979.
24. Stearns ME and Wang M: Immunoassays of the metalloproteinase (MMP-2,9) and tissue inhibitor of metalloproteinase (TIMP-1,2) levels in non-invasive and metastatic PC-3 clones. Effects of taxol. Oncol Res 6: 195-202, 1995.
25. Stearns ME, Wang M and Stearns M: IL-10 blocks collagen IV invasion by 'Invasion Stimulating Factor' activated PC-3 ML cells: up regulation of TIMP-1 expression. Oncol Res 7: 157-163, 1996.
26. Peehl DM: Culture of human prostatic epithelial cells. In: Culture of Epithelial Cells. Freshney IA (ed). Wiley Liss, Inc., New York, pp159-180, 1992.
27. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 72: 248-254, 1976.
28. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983.
29. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchel JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testine. Cancer Res 47: 936-942, 1987.
30. Carmichael J, De Graff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated calorimetric assay: assessment of radiosensitivity. Cancer Res 47: 943-946, 1987.
31. La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Linehan WM and Myers CE: Effect of suramin on human prostate cancer cells in vitro. J Urol 145: 393-398, 1991.
32. Peehl DM and Stamey TA: Serial propagation of adult human prostatic epithelial cells with cholera toxin. In Vitro 20: 981-986, 1984.
33. Peehl DM, Wong ST and Stamey TA: Clonal growth characteristics of adult human prostatic epithelial cells. In Vitro 24: 530-536, 1988.
34. Brothman AR, Peehl DM, Patel AM and McNeal JE: Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 50: 3795-3803, 1990.
35. Sibley PEC, Harper ME, Peeling WB and Griffiths K: Growth hormone and prostatic tumours: localization using a monoclonal human growth hormone antibody. J Endocrinol 103: 311-315, 1984.
36. Sibley PEC, Harper ME, Joyce BG, Peeling WB and Griffiths K: The immunocytochemical detection of protein hormones in human prostatic tissues. Prostate 2: 175-185, 1981.
37. Farnsworth WE, Slaunwhite WR Jr, Sharma M, Oseko F, Brown JR and Bonder MJ: Interaction of prolactin and testosterone in the human prostate. Urol Res 9: 79-88, 1981.
38. Povoa H, Lima-Renzende MJ, Almeida PCC, Coelho De Souza A and Sargentelli L: Immunoreactive insulin in human semen. Acta Biol Med 29: 183-188, 1972.
39. Sathe VS, Sheth NA, Sheth AR and Phadke MA: Biosynthesis and localization of inhibin in human prostate. Prostate 10: 33-43, 1987.
40. Garde SV, Sheth AR, Shah MG and Kulkarni SA: Prostate - an extrapituitary source of follicle-stimulating hormone (FSH): occurrence, localization, and de novo biosynthesis and its hormonal modulation in primates and rodents. Prostate 18: 271-287, 1991.
41. Garde SV and Sheth AR: Prostate - an extrapituitary source of follicle stimulating hormone. In: Follicle Stimulating Hormone. Dunn MH and Schwartz NB (eds). Springer-Verlag, Berlin, pp323-329, 1991.
42. Sheth AR, Garde SV, Hurkadli KS, Shah MG and Sheth NA: Prostate-A 'non-classical' source of FSH and inhibin: are these hormones involves in the etiopathology of prostatic tumors? In: Perspective in Primates Reproductive Biology. Moudgal NR, Yoshinaga K, Rao AJ and Adiga PR (eds). Wiley Eastern Limited, New Delhi, pp235-241, 1991.
43. Garde S, Sheth A, Porter AT and Pienta KJ: Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 22: 225-233, 1993.
44. Kogure K, Omata W, Kanzaki M, Zhang Y-Q, Yasuda H, Mine T and Kojima I: A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 108: 1136-1142, 1995.
45. Peehl DM, Leung GK and Wong ST: Keratin expression: a measure of phenotypic modulation of human prostatic epithelial cells by growth inhibitory factors. Cell Tissue Res 277: 11-18, 1994.
46. Wilding G, Zugmeier G, Knabbe C, Flanders K and Gelmann E: Differential effects of transforming growth factor on human prostate cancer cells in vitro. Mol Cell Endocrinol 62: 79-86, 1989.